title: The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
abstract: OBJECTIVE
  We tested the association between PON1 polymorphism, PON1 activity, oxidative susceptibility of LDL and coronary artery disease in Egyptians.
  
  
  METHODS
  PON1 polymorphism, serum PON1 activity, lipoprotein oxidation susceptibility and lipid profile were measured.
  
  
  RESULTS
  Levels of HDL and paraoxonase activity were significantly decreased in CAD patients compared to control group, and in patients with three vessels compared to those of single or two vessels disease. High-activity allele (R) has a more atherogenic lipid profile than for the low activity allele (Q). PON1 RR genotype has nine fold risks to develop CAD in Egyptians while those with PON1 QR genotype have four fold risks.
  
  
  CONCLUSIONS
  The PON1 activity is lower in subject with CAD and there is a significant relationship between activity of PON1 and the severity of coronary atherosclerosis. Also, we provide evidence of a significant association between R allele of the PON1 polymorphism and the development of coronary artery disease.
authors.affiliation: Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. randahussiny@yahoo.com
authors.forename: Randa H
authors.initials: RH
authors.lastname: Mohamed
authors.forename: Rasha H
authors.initials: RH
authors.lastname: Mohamed
authors.forename: Rehab A
authors.initials: RA
authors.lastname: Karam
authors.forename: Tarek A
authors.initials: TA
authors.lastname: Abd El-Aziz
mesh_terms: D000328:Adult; D000368:Aged; D043303:Aryldialkylphosphatase / Q000235:genetics*; D016022:Case-Control Studies; D003324:Coronary Artery Disease / Q000097:blood / Q000201:enzymology* / Q000235:genetics*; D004534:Egypt; D004789:Enzyme Activation / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D020641:Polymorphism, Single Nucleotide / Q000502:physiology; D011401:Promoter Regions, Genetic / Q000235:genetics; D012720:Severity of Illness Index
chemical_list: D008055:Lipids; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human